BALA CYNWYD, Pa., July 21, 2012 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Conmed Healthcare Management, Inc. ("Conmed" or the "Company") (NYSE MKT- CONM-News) relating to the proposed acquisition by Correct Care Solutions, LLC ("Correct Care").
Under the terms of the transaction, Conmed shareholders would receive only $3.95 in cash for each share of Conmed stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Conmed for not acting in the Company's shareholders' best interests in connection with the sale process to Correct Care. The transaction may undervalue Conmed as an analyst has placed a $5.00 per share price target on Conmed stock.
If you own shares of Conmed stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com visiting http://brodsky-smith.com/450-conm-conmed-healthcare-management-inc.html, or by calling toll free 877-LEGAL-90.
SOURCE Brodsky & Smith, LLC
